Your browser doesn't support javascript.
loading
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
Spyropoulos, Alex C; Raskob, Gary E; Cohen, Alexander T; Ageno, Walter; Weitz, Jeffrey I; Spiro, Theodore E; Lu, Wentao; Lipardi, Concetta; Albers, Gregory W; Elliott, C Gregory; Halperin, Jonathan L; Hiatt, William R; Maynard, Gregory; Steg, P Gabriel; Sugarmann, Chiara; Barnathan, Elliot S.
Afiliación
  • Spyropoulos AC; Feinstein Institute for Medical Research, Department of Medicine, Anticoagulation and Clinical Thrombosis Services Northwell Health at Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York (A.C.S.).
  • Raskob GE; Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City (G.E.R.).
  • Cohen AT; Department of Hematological Medicine, Guy's and St Thomas'/National Health Service Foundation Trust, King's College London, United Kingdom (A.T.C.).
  • Ageno W; Department of Medicine and Surgery, University of Insubria, Varese, Italy (W.A.).
  • Weitz JI; McMaster University, and Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada (J.I.W.).
  • Spiro TE; Bayer US, LLC, Whippany, NJ (T.E.S.).
  • Lu W; Biostatistics Department (W.L.), Janssen Research and Development, LLC, Raritan, NJ.
  • Lipardi C; Cardiovascular Clinical Development, Janssen Research and Development, LLC, Raritan, NJ (C.L., C.S., E.S.B.).
  • Albers GW; Stanford Stroke Center, Stanford Medical Center, Stanford University, Palo Alto, CA (G.W.A.).
  • Elliott CG; Department of Medicine, University of Utah and Intermountain Healthcare, Salt Lake City (C.G.E.).
  • Halperin JL; Cardiovascular Institute, Mount Sinai Medical Center, New York (J.L.H.).
  • Hiatt WR; Division of Cardiology, University of Colorado School of Medicine, and CPC Clinical Research, Aurora (W.R.H.).
  • Maynard G; University of California at Davis, Sacramento (G.M.).
  • Steg PG; Université de Paris, INSERM UMR-1148 F-75018 Paris, and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, France (P.G.S.).
  • Sugarmann C; Cardiovascular Clinical Development, Janssen Research and Development, LLC, Raritan, NJ (C.L., C.S., E.S.B.).
  • Barnathan ES; Cardiovascular Clinical Development, Janssen Research and Development, LLC, Raritan, NJ (C.L., C.S., E.S.B.).
Circulation ; 145(19): 1471-1479, 2022 05 10.
Article en En | MEDLINE | ID: mdl-35389229
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tromboembolia Venosa / Rivaroxabán Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Circulation Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tromboembolia Venosa / Rivaroxabán Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Circulation Año: 2022 Tipo del documento: Article